Cardica Announces Completion Of First U.S. Procedure Using MicroCutter XCHANGE™ 30 Stapling Device

    Cardica Announces Completion Of First U.S. Procedure Using MicroCutter
                         XCHANGE™ 30 Stapling Device

PR Newswire

REDWOOD CITY, Calif., March 11, 2014

REDWOOD CITY, Calif., March 11, 2014 /PRNewswire/ --Cardica, Inc. (Nasdaq:
CRDC) today announced that Juan-Carlos Verdeja, M.D., F.A.C.S., completed the
first surgical procedure in the United States using theMicroCutter XCHANGE™
30 cutting and stapling device at West Kendall Baptist Hospital in Florida on
March 3, 2014. The MicroCutter XCHANGE 30 is the only articulating five
millimeter surgical stapler available today.

"The availability of the MicroCutter XCHANGE 30 in the U.S. has been a long
time coming," said Dr. Verdeja, medical director of emergency surgical
services for Baptist Health South Florida. "We have been waiting for a smaller
stapler for decades and I believe having the MicroCutter at our disposal can
change the way we perform some less invasive surgeries. The ability to use
smaller and fewer access ports equates to less patient trauma, and improved
articulation equates to more versatility. This appendectomy today was only one
example of where I believe we will see the MicroCutter provide value. I am
truly excited for our patients and the surgical community."

AboutCardica
Cardicadesigns and manufactures proprietary stapling and anastomotic devices
for cardiac and laparoscopic surgical procedures.Cardica's technology
portfolio is intended to reduce operating time and facilitate
minimally-invasive and robot-assisted surgeries. Cardica's MicroCutter
XCHANGE™ 30, a cartridge-based articulating surgical stapling device with a
five-millimeter shaft diameter, is manufactured and cleared for use in a
variety of gastrointestinal procedures and appendectomies in the United
States, and is marketed for a wide range of surgical procedures in Europe.
Cardicais developing the Cardica^® MicroCutter XCHANGE™ 45, a cartridge-based
microcutter device with an eight-millimeter shaft to be used in a variety of
procedures, including bariatric, colorectal, thoracic and general surgery. The
Cardica MicroCutter XCHANGE 45 product requires 510(k) review and CE Mark and
is not yet commercially available in the U.S. or internationally. In addition,
Cardica manufactures and markets its automated anastomosis systems, the
C-Port^® Distal Anastomosis Systems and PAS-Port^® Proximal Anastomosis System
for coronary artery bypass graft (CABG) surgery, and has shipped over 49,000
units throughout the world.

Forward-Looking Statements
The statements in this press release regarding the benefits expected for
patients from Cardica's MicroCutter XCHANGE 30 and cartridges are
"forward-looking statements." There are a number of important factors that
could cause Cardica's results to differ materially from those indicated by
this forward-looking statement, including: that Cardica may not be successful
in its efforts to commercialize the XCHANGE 30 due to unanticipated technical
or other difficulties; that prospective customers in the United States may not
perceive the benefits of the XCHANGE 30 to be sufficient to warrant its
purchase; that prospective customers in the United States may be constrained
by pricing pressures or purchasing requirements in the hospitals and
facilities in which they work, which could prevent them from purchasing the
XCHANGE 30; as well as other risks detailed from time to time in Cardica's
reports filed with the U.S. Securities and Exchange Commission, including its
Quarterly Report on Form 10-Q for the quarter endedDecember 31, 2013, under
the caption "Risk Factors," filed on February 5, 2014. Cardica expressly
disclaims any obligation or undertaking to release publicly any updates or
revisions to any forward-looking statements contained herein. You are
encouraged to read Cardica's reports filed with the U.S. Securities and
Exchange Commission, available at www.sec.gov.

SOURCE Cardica, Inc.

Website: http://www.cardica.com
Contact: Bob Newell, Vice President, Finance and Chief Financial Officer,
(650) 331-7133, investors@cardica.com
 
Press spacebar to pause and continue. Press esc to stop.